Homeowners insurance rates could reemerge in Illinois legislative session
Gov. JB Pritzker called for the legislation last summer after
A bill to give the
The following day, however, the bill's chief House sponsor, Rep.
"They get a second bite at the apple,"
Gabel told Capitol News Illinois through a spokesperson this week that no decision had been made about calling the bill for a second vote. But Martin said people in the industry have heard the bill could be called as early as Tuesday, when the
Current environment
The controversy over
Advocates for the legislation argue that every state in the nation except
In the wake of
"As states across the country face even more extreme weather than we do, we need to make sure
"We have never seen anything like that, and we would argue very strongly that that does not happen and cannot happen based on the actuarial data that the companies have to provide in
Proposed changes
Pritzker's call for new legislation to regulate homeowners insurance rates led to intense negotiations between the governor's office, legislative leaders and the insurance industry. But the final language wasn't unveiled until the final hours of the fall veto session.
The language was put into a
The bill also would leave in place the state's "use-and-file" method of setting rates, meaning companies would not have to seek advance clearance from state regulators before implementing rate changes. But it would require them to give consumers at least 60 days' advance notice before raising rates by 10% or more.
The major sticking point for the insurance industry, however, was the provision giving the
Under the proposed language, if the agency found a company's rates to be excessive, inadequate or unfairly discriminatory, it would send the company a notice specifying the agency's objections. Companies then would be allowed to defend their rates at an administrative hearing. But after that hearing, if the agency still believed the rates violated standards of the law, it would be authorized to order the company to rebate excess charges back to customers.
According to Martin, the industry's main objection to that language was that there was no limit on how far back in time the agency could look in its rate review process.
"They can go back forever," he said.
"We just believe that, in all of the negotiations that we had, for them to come in at the last minute with this type of language, of the changes that they made, was just something that we thought was really unfair," Martin said.
The
Pritzker is scheduled to deliver his annual budget and State of the State address to a joint session of the



Gold Declines As U.S. Dollar Strengthens
Delaware weighs cutting GLP-1 coverage on state plan
Advisor News
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
More Annuity NewsHealth/Employee Benefits News
- We can't afford to let Democrats lead health care 'reform' | Opinion
- Expanding Medicaid coverage lowered death rates for young adults with kidney failure
- GLP-1s: Rewriting the relationship between pharmacy benefits and stop-loss
- Studies from Denise Wolff et al Have Provided New Data on Atopic Dermatitis (AMCP Market Insights: Beyond skin deep on the role of managed care in moderate to severe atopic dermatitis): Skin Diseases and Conditions – Atopic Dermatitis
- New Clinical Trials and Studies Findings from RAND Corporation Described (Benefit design and consumer information: results from a randomized trial): Clinical Research – Clinical Trials and Studies
More Health/Employee Benefits NewsLife Insurance News
- 3 ways AI can help close the gap for women’s insurance coverage
- Best’s Market Segment Report: AM Best Revises Outlook on Italy’s Life Insurance Segment to Stable From Negative
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Dan Scholz to receive NAIFA’s Terry Headley Lifetime Defender Award
- Best’s Special Report: US Property/Casualty and Health Insurers Exceed Cost of Capital; Life Insurers Narrowly Miss
More Life Insurance News